drugset / Trial / NCT07754331

Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin

NCT07754331 ↗

Phase 1 Recruiting 10 enrolled AstraZeneca Fortrea · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of HD on single oral dose PK, safety, and tolerability of balcinrenone/dapagliflozin to male and female participants with kidney failure on intermittent HD.

Timeline

Start
2026-08-06
Primary completion
2026-12-03
Completion
2026-12-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Balcinrenone Small molecule 40 mg Oral
Subject Dapagliflozin Small molecule 10 mg Oral

Indications